# A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants

> **NCT07681479** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Fujian Shengdi Pharmaceutical Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Fluid Retention Due to Heart Failure

## Interventions

- **DRUG:** [14C]HRS-9057

## Key facts

- **NCT ID:** NCT07681479
- **Lead sponsor:** Fujian Shengdi Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-08-11
- **Primary completion:** 2026-08-11
- **Final completion:** 2026-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681479, "A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07681479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*